The Myval THV series, known for its innovative contributions to transcatheter aortic valve replacement (TAVR) procedures, ...

Edwards' SAPIEN 3 Ultra RESILIA Valve continues to deliver excellent outcomes for patients in real-world data.

Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter aortic ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

NEW YORK, NY / ACCESSWIRE / November 26, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to ...

Boston Scientific (NYSE:BSX) shared data highlighting the safety and efficacy of its Acurate Prime XL aortic valve system.

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

The randomized trial will use Tempus’ platform to find patients who are eligible for interventions such as TAVR but do not ...

RADNOR, PA / ACCESSWIRE / November 25, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a ...

Abbott today announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) ...

Kessler Topaz Meltzer & Check, LLP encourages Edwards investors who have suffered significant losses to contact the firm directly to acquire more information.

Survivors of cardiovascular disease, which is the number one killer in the Cayman Islands, were honoured recently by the ...